Effects of Intensive Glucose Lowering in Type 2 Diabetes

Yearbook of Endocrinology
doi 10.1016/s0084-3741(09)79370-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Blood Glucose-Lowering Therapy in Adults With Type 2 Diabetes

Nurse Prescribing
2016English

Intensive Glucose Control and Macrovascular Outcomes in Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Seasonal Variation in Severe Glucose-Lowering Drug-Induced Hypoglycemia in Patients With Type 2 Diabetes

Internal Medicine
Internal MedicineMedicine
2019English

Intensive Lipid Lowering by Statin Therapy Does Not Improve Vasoreactivity in Patients With Type 2 Diabetes

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2002English

Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-Of-The-Art Review

Mayo Clinic Proceedings
Medicine
2018English

Glucose-Lowering Effect of Whey Protein Depends Upon Clinical Characteristics of Patients With Type 2 Diabetes

BMJ Open Diabetes Research and Care
EndocrinologyMetabolismDiabetes
2017English

Bromocriptine as a Potential Glucose-Lowering Agent for the Treatment of Prolactinoma With Type 2 Diabetes

Internal Medicine
Internal MedicineMedicine
2019English

Intensive Glucose Lowering and Cardiovascular Disease Prevention in Diabetes: Reconciling the Recent Clinical Trial Data

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

Early Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes: Study Based on Continuous Glucose Monitoring

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy